Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Cytotechnology|February 9, 2018
Combination treatment of all-trans retinoic acid (ATRA) and γ-secretase inhibitor (DAPT) cause growth inhibition and apoptosis induction in the human gastric cancer cell lineElham Patrad, Ali Niapour, Faris Farassati, et al.Plos One|August 5, 2009
Utilizing ras signaling pathway to direct selective replication of herpes simplex virus-1Weihong Pan, Vidya Bodempudi, Tuba Esfandyari, et al.Oncotargets and Therapy|February 7, 2018
Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, IranFarnaz Boostani, Roya Dolatkhah, Ashraf Fakhrjou, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 10, 2015
Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cellsNowruz Najafzadeh, Mohammad Mazani, Asadollah Abbasi, et al.Clinical Case Reports|March 8, 2017
A novel KRAS gene mutation report in sporadic colorectal cancer, from Northwest of IranRoya Dolatkhah, Mohammad Hossein Somi, Iraj Asvadi Kermani, et al.Asian Pacific Journal of Cancer Prevention : APJCP|August 25, 2018
Main Risk Factors Association with Proto-Oncogene Mutations in Colorectal CancerRoya Dolatkhah, Mohammad Hossein Somi, Reza Shabanloei, et al.Cancer Cell International|May 19, 2004
Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patientsSilke Frahm, Andreas Kurtz, Lan Kluwe, et al.Journal of Cancer Epidemiology|February 17, 2015
Colorectal cancer in iran: molecular epidemiology and screening strategiesRoya Dolatkhah, Mohammad Hossein Somi, Mortaza Jabbarpour Bonyadi, et al.Bioimpacts : BI|January 20, 2021
Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancerRoya Dolatkhah, Saeed Dastgiri, Amir Taher Eftekhar Sadat, et al.Current Pharmaceutical Biotechnology|July 12, 2011
Pro-oncogenic cell signaling machinery as a target for oncolytic virusesEmma Borrego-Diaz, Rajesh Mathew, Dana Hawkinson, et al.Pageof 3